1. The little-known company targeting 438x potential business growth as it capitalizes on the confluence of two megatrends developing in American society. A true rising star, and NEVER BEFORE RECOMMENDED BY THE MOTLEY FOOL.
2. Talk about a reopening trade! This recent IPO (and no, it’s not Redfin or Zillow) is aimed directly at the red-hot residential real estate market, and our team thinks it has 500% upside potential. And again, NEVER BEFORE RECOMMENDED BY THE MOTLEY FOOL.
3. The tiny (sub $800 million market cap) healthcare stock whose lead drug could be the new gold standard for fighting a debilitating disease – and potentially worth as much as $5 billion per year in sales! A chance to do well by doing good – and yet again, NEVER BEFORE RECOMMENDED BY THE MOTLEY FOOL.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.